Greg Simon, MD, MPH, is a psychiatrist and senior investigator well-known for his extensive research on practical approaches to improving mental health care. He seeks to develop and evaluate effective real-world strategies that support better mental health and wellness. Current areas of emphasis include identifying and assessing suicide risk, improving care for treatment-resistant depression, and reducing racial and ethnic disparities in mental health care.
Dr. Simon leads the Mental Health Research Network (MHRN), a consortium of research centers affiliated with 13 large health systems across the United States, including Kaiser Permanente Washington. This network, originally funded through a cooperative agreement with the National Institute of Mental Health, aims to improve the efficiency, relevance, and impact of mental health clinical and health services research. The MHRN is exploring a broad range of issues—including suicide prevention, improving heart health in people with serious mental illness, using electronic medical records to improve follow-up care for depression, and understanding the causes of racial and ethnic disparities in mental health care.
Dr. Simon and his MHRN colleagues have conducted several large studies across MHRN health systems, including:
Dr. Simon sits on the editorial board for the journal General Hospital Psychiatry, and co-chairs the National Academy of Medicine’s Forum on Drug Discovery, Development and Translation.. Dr. Simon has practiced adult psychiatry in Kaiser Permanente Washington's Mental Health and Wellness Service since 1990. He is also a professor in the department of Health Systems Science at the Bernard J Tyson Kaiser Permanente School of Medicine and an adjunct professor inPsychiatry and Behavioral Dciences at the University of Washington.
Depression; bipolar disorder; suicide prevention; self-management; treatment adherence
Comorbidity of mental health conditions with obesity, diabetes, heart disease, and substance use disorders.
Simiola V, Miller-Matero LR, Erickson C, Nie S, Kazan R, Gootee J, Simon GE Patient perspectives for improving treatment initiation for new episodes of depression in historically minoritized racial and ethnic groups 2024 Jul;89:69-74. doi: 10.1016/j.genhosppsych.2024.05.011. Epub 2024-05-21. PubMed
Boggs JM, Richards J, Simon G, Aguirre-Miyamoto EM, Barton LJ, Beck A, Beidas RS, Bruschke C, Buckingham ET, Buttlaire S, Clarke G, Coleman K, Flores JP, Frank C, Penfold RB, Richardson L, Ryan JM, Schoenbaum M, Sterling S, Stewart C, Yarborough BJH, Yeh HH, Ahmedani B Suicide Screening, Risk Assessment, and Lethal Means Counseling During Zero Suicide Implementation 2024 Jul;75(7):638-645. doi: 10.1176/appi.ps.20230211. Epub 2024-04-03. PubMed
Flores JP, Kahn G, Penfold RB, Stuart EA, Ahmedani BK, Beck A, Boggs JM, Coleman KJ, Daida YG, Lynch FL, Richards JE, Rossom RC, Simon GE, Wilcox HC Adolescents Who Do Not Endorse Risk via the Patient Health Questionnaire Before Self-Harm or Suicide 2024 Jul;81(7):717-726. doi: 10.1001/jamapsychiatry.2024.0603. Epub 2024-04-24. PubMed
Miller-Matero LR, Knowlton G, Vagnini KM, Yeh HH, Rossom RC, Penfold RB, Simon GE, Akinyemi E, Abdole L, Hooker SA, Owen-Smith AA, Ahmedani BK The rapid shift to virtual mental health care: Examining psychotherapy disruption by rurality status 2024 Jun;40(3):500-508. doi: 10.1111/jrh.12818. Epub 2023-12-26. PubMed
Sesay MM, McCracken CE, Stewart C, Simon G, Penfold R, Ahmedani B, Rossom RC, Lu CY, Beck A, Coleman KJ, Daida Y, Lynch FL, Zeber J, Copeland L, Owen-Smith A Short report: Transition to International Classification of Diseases, 10th Revision and the prevalence of autism in a cohort of healthcare systems 2024 May;28(5):1316-1321. doi: 10.1177/13623613231220687. Epub 2024-01-19. PubMed
Simon GE, Cruz M, Boggs JM, Beck A, Shortreed SM, Coley RY Predicting Outcomes of Antidepressant Treatment in Community Practice Settings 2024 May;75(5):419-426. doi: 10.1176/appi.ps.20230380. Epub 2023-12-05. PubMed
Patel SR, Yeh HH, Eke-Usim A, Ahmedani BK, Rossom RC, Miller-Matero L, Simon GE, Penfold RB, Owen-Smith A, Beebani G, Akinyemi E Reduced Disruption in Psychotherapy Visits Among Older Adults During the COVID-19 Pandemic 2024 May;32(5):644-645. doi: 10.1016/j.jagp.2023.12.023. Epub 2024-01-03. PubMed
Simon GE, Rossom RC, Iturralde E, Ahmedani BK, Waring SC, Owen-Smith AA, Sterling SA, Miley K, Stults CD, Daida YG, Lynch FL, Beck A, Sanchez K, Coleman KJ, Shortreed SM Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine 2024 Apr 29;85(2). doi: 10.4088/JCP.23m14833. Epub 2024-04-29. PubMed
Richards JA, Kuo E, Stewart C, Shulman L, Parrish R, Whiteside U, Boggs JM, Simon GE, Rowhani-Rahbar A, Betz ME Reducing Firearm Access for Suicide Prevention: Implementation Evaluation of the Web-Based "Lock to Live" Decision Aid in Routine Health Care Encounters 2024 Apr 22;12:e48007. doi: 10.2196/48007. Epub 2024-04-22. PubMed
Simon GE, Johnson E, Shortreed SM, Ziebell RA, Rossom RC, Ahmedani BK, Coleman KJ, Beck A, Lynch FL, Daida YG Predicting suicide death after emergency department visits with mental health or self-harm diagnoses 2024 Mar;87:13-19. doi: 10.1016/j.genhosppsych.2024.01.009. Epub 2024-01-22. PubMed
In a new multistate study, the Zero Suicide Model reduced suicide rates by 25%.
Safety planning and risk screening improved outcomes for adult patients.
A new grant funds modeling work to make personalized treatment possible.
KPWHRI research finds ways to increase use of a firearm safety tool.
Study finds that many patients who might benefit from clozapine don’t receive it.